A A A
MENU

Arrhythmia Alliance News & Events

All News

The World Stroke Congress 2018 is hosting a symposium with a panel of experts to discuss Atrial Fibrillation and various ways to advance policies and advocacy initiatives that can help reduce the risk of AF-related stroke.

Our very own Trudie Lobaan will be presenting - Read more to tune in tomorrow at 13:00h EST - 18:00h BST.

Read more [links to external site]

Cardiac rhythm News - 12 October 2018

All the lastest here.

Read more [links to external site]

Special supplement celebrates advances in cardiac pacing – a 60th anniversary update

Read more

October Patient e-News 2018

Get all the latest from us for this month and register for Patients Day 2018!

Read more [links to external site]

Making promises for all our hearts

World Heart Day is the world’s biggest awareness-raising platform for cardiovascular disease. The annual campaign brings together individuals, families, communities and organisations around the world to participate in activities to take charge of their heart health and that of others. This year’s theme for World Heart Day is to make a promise... for my heart, for your heart, for all our hearts.

Read more [links to external site]

We’re supporting the Cardiovascular Health campaign with Media Planet UK

Read more

A Mother’s Mission to Educate the World About Arrhythmia

When Trudie Lobban’s daughter Francesca, now 29, was a baby, the girl had fainting episodes up to eight times a day. It took three years until Francesca was diagnosed with Reflex Anoxic Seizures (RAS), a condition that caused her heart to briefly stop.

Read more [links to external site]

Should We Switch Patients Who Appear to Be Optimally Anticoagulated on Warfarin to DOACs?*

wo different types of oral anticoagulants (OACs) are currently available to reduce the risk of stroke/systemic embolism (SE) in patients with atrial fibrillation (AF): vitamin K antagonists (VKAs) and direct OACs (DOACs) (1).

Read more [links to external site]

An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by right ventricular myocardial replacement and life-threatening ventricular arrhythmias. Desmosomal gene mutations are sometimes identified, but clinical and genetic diagnosis remains challenging. Desmosomal skin disorders can be caused by desmosomal gene mutations or autoantibodies. We sought to determine if anti-desmosome antibodies are present in subjects with ARVC.

Read more [links to external site]

Congratulations to the Boston Scientific EU UK Rhythm Management team

Read more

Share

Send us your feedback

Download Resource

To download our information resource and receive regular updates from Arrhythmia Alliance please enter your details below*:

No thanks

*Please note you can unsubscribe from our mailing list at any time

This link will take you to the site

Stay on this site